In this context, an effect of this molecule on the restoration of an appropriate endogenous GIP/GLP-1 interrelationship cannot be excluded and in addition may pose the background to design new interventions aimed at restoring balanced incretin responses in early T2D by improving incretin sensitivity rather than increasing circulating incretins levels (23-25). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.